Dr. Sashank Reddy is Assistant Professor of Plastic and Reconstructive Surgery at the Johns Hopkins University School of Medicine and Medical Director of Johns Hopkins Technology Ventures. Dr. Reddy received his undergraduate degree with University Honors from Johns Hopkins where he studied Biology and Humanistic Studies as one of the University’s Beneficial Hodson Scholars. He went on to complete his MD and PhD studies at Harvard Medical School under the auspices of the NIH Medical Scientist Training Program. Dr. Reddy’s thesis work on posttranslational control of the cell cycle was accomplished in the laboratory of Marc Kirschner. His current research efforts center on mechanisms of regeneration and homeostasis in skin and development of nanomaterials to support tissue regeneration and cell delivery. His discoveries have been published in leading journals including Nature, Cell, Cell Stem Cell and Science Translational Medicine. Dr. Reddy is also an accomplished entrepreneur and biomedical innovator. Earlier in his career he was at Third Rock Ventures where he served as a member of the founding team at Eleven Biotherapeutics (NASDAQ: SESN). He is currently founder and President of LifeSprout, Inc., a privately-held company developing novel synthetic analogues of soft tissue for reconstructive and aesthetic medicine. In his role as Medical Director of Johns Hopkins Technology Ventures, Dr. Reddy advises faculty and University administration on enhancing the impact of discoveries through new company creation and corporate partnerships. Dr. Reddy’s overall aim is to integrate science, medicine, and entrepreneurship to advance patient care.